From her GLP-1 weight loss journey to her new partnership with Ro, Serena Williams has sparked months of debate. Here's why her transformation remains so controversial.

Blockbuster weight-loss drugs are being linked to a rare but upsetting side effect that’s showing up in the shower drain. As ...

GLP-1 medications may be new, but the belief that smaller bodies hold the answer is not. What can two centuries of ...

Novo Nordisk filed a lawsuit against Eli Lilly that alleges advertising falsely claims Wegovy is weaker than it is.

The lawsuit alleges that Eli Lilly misled consumers by using outdated clinical trial data to make its drugs appear more ...

Novo Nordisk sued rival drugmaker Eli Lilly, alleging false advertising claims about relative weight-loss drug performance.

In today’s healthcare landscape, people are looking for experiences that feel human, supportive and connected. Patients, caregivers and consumers are looking for brands they can relate to and trust.

Copyright 2026 The Associated Press. All Rights Reserved. Copyright 2026 The Associated Press. All Rights Reserved. Add AP News on Google Add AP News as your ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Then Serena Williams returned to professional tennis by competing in ...

Serena Williams' Wimbledon return has come to an abrupt end after she announced her withdrawal from ladies doubles competition on July 4, even before she and her sister Venus could take the court ...